Amber Therapeutics
Oxford, United Kingdom · StartupMedtech spin-out developing implantable neuromodulation devices to treat pelvic and nervous system disorders.
Founders, investors, and support organizations active in Medical Devices.
Medtech spin-out developing implantable neuromodulation devices to treat pelvic and nervous system disorders.
A venture capital firm active in the startup ecosystem, supporting early-stage companies with funding and strategic guidance, operating as an incubator.
Founded 2008. Specialist VC investing in biotech, pharma, and medical devices with a transatlantic presence.
Kerecis is an Icelandic biotech and medical technology company known for developing wound-healing products derived from fish skin. Its work is notable because it turns a locally abundant natural material into a clinically relevant regenerative scaffold used in difficult wound-care cases, including burns, trauma, and chronic ulcers. The biological rationale and manufacturing approach set it apart from software-led health companies: this is a deep life-science and materials business built around research, regulatory rigor, and medical adoption. In the European ecosystem, Kerecis is a useful example of how world-class biotech can emerge from a small geography when the product is grounded in differentiated science and clear clinical utility. It expands the directory's health coverage into advanced materials and tissue regeneration, complementing digital health and wearable platforms without overlapping with them. For the broader startup map, Kerecis shows that high-impact European innovation is not limited to apps or infrastructure, but also includes biologically sophisticated products with global medical significance.
Founded 2002. Life sciences VC investing in biotech, medtech, and diagnostics across Europe.